Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation
Immunity · 2023-08 · 56 (8) · 1844-1861.e6
DOI: 10.1016/j.immuni.2023.06.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2023-08. Verfasst von Pulavendran Sivasami und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Psoriasis. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Obesity is a major risk factor for psoriasis, but how obesity disrupts the regulatory mechanisms that keep skin inflammation in check is unclear. Here, we found that skin was enriched with a unique population of CD4+Foxp3+ regulatory T (Treg) cells expressing the nuclear receptor peroxisome proliferation-activated receptor gamma (PPARγ). PPARγ drove a distinctive transcriptional program and functional suppression of IL-17A+ γδ T cell-mediated psoriatic inflammation. Diet-induced obesity, however, resulted in a reduction of PPARγ+ skin Treg cells and a corresponding loss of control over IL-17A+ γδ T cell-mediated inflammation. Mechanistically, PPARγ+ skin Treg cells preferentially took up elevated levels of long-chain free fatty acids in obese mice, which led to cellular lipotoxicity, oxidative stress, and mitochondrial dysfunction. Harnessing the anti-inflammatory properties of these PPARγ+ skin Treg cells could have therapeutic potential for obesity-associated inflammatory skin diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USA; Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atl…
- Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA; Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USA; Department of Dermatology, Emory University School of Medicine, A…
- Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, E…
Förderung
- BLRD VA
- NCI NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Sivasami, P., Elkins, C., Diaz-Saldana, P. P., Goss, K., Peng, A., Hamersky, M., Bae, J., Xu, M., Pollack, B. P., Horwitz, E. M., Scharer, C. D., Seldin, L., & Li, C. (2023). Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity, 56(8), 1844-1861.e6. https://doi.org/10.1016/j.immuni.2023.06.021
Vancouver
Sivasami P, Elkins C, Diaz-Saldana PP, Goss K, Peng A, Hamersky M, et al. Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity. 2023;56(8):1844-1861.e6. doi:10.1016/j.immuni.2023.06.021
BibTeX
@article{Sivasami2023,
author = {Sivasami, Pulavendran and Elkins, Cody and Diaz-Saldana, Pamela P and Goss, Kyndal and Peng, Amy and Hamersky, Michael and Bae, Jennifer and Xu, Miaoer and Pollack, Brian P and Horwitz, Edwin M and Scharer, Christopher D and Seldin, Lindsey and Li, Chaoran},
title = {Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation},
journal = {Immunity},
year = {2023},
volume = {56},
number = {8},
pages = {1844--1861.e6},
doi = {10.1016/j.immuni.2023.06.021}
}
EUVIMED